al. investigated that IGFBP5 was overexpressed non-responders of chemotherapy; meanwhile, CRISPR-mediated deletion of IGFBP5 signature genes in the U251 human GBM cell line could elevate the response to chemotherapy26. This evidence concerns the gene IGFBP5 and glioblastoma.